Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erwin Schleicher

Showing results (1-10 of 97) with videos related to

Pageof 10
Sort By:
Analytical and Bioanalytical Chemistry|January 24, 2009
Diagnostic assaysErwin Schleicher
Analytical and Bioanalytical Chemistry|December 3, 2005
The clinical chemistry laboratory: current status, problems and diagnostic prospectsErwin Schleicher
Analytical and Bioanalytical Chemistry|December 24, 2008
Inflammation markers in point-of-care testing (POCT)Albrecht Pfäfflin, Erwin Schleicher
Clinical Chemistry and Laboratory Medicine|August 1, 2009
Impeded centrifugation in plasmocytoma serumAlbrecht Pfäfflin, Erwin Schleicher
Annals of Clinical Biochemistry|January 20, 2009
Interference of paracetamol (acetaminophen) with a commercially available high-performance liquid chromatography analysis of serotonin leading to falsely low serotonin levelsAlbrecht Pfäfflin, Karsten Müssig, Erwin Schleicher
Analytical and Bioanalytical Chemistry|November 20, 2010
Production and analytical characterization of neopterin immunoreagents for biosensor developmentsIvo Cernoch, Erwin Schleicher, Milan Franek
Annals of the New York Academy of Sciences|May 2, 2008
The 9th International Symposium on the Maillard Reaction. PrefaceErwin Schleicher, Veronika Somoza, Peter Schieberle
Clinical Chemistry|October 24, 2007
3-O-methyldopamine (3-O-methoxytyramine) interferes with the internal standard 3,4-dihydroxybenzylamine in a plasma catecholamine HPLC methodAlbrecht Pfäfflin, Erwin Schleicher, Karsten Müssig
Clinical Kidney Journal|February 10, 2021
Urinary fetuin-A peptides as a new marker for impaired kidney function in patients with type 2 diabetesPedro Magalhães, Petra Zürbig, Harald Mischak, et al.
Biotechnology Advances|February 26, 2019
Harmonization of immunoassays for biomarkers in diabetes mellitusSebastian Hörber, Peter Achenbach, Erwin Schleicher, et al.
Pageof 10

Showing results (1-10 of 97) with videos related to

Sort By:
Pageof 10
Analytical and Bioanalytical Chemistry|January 24, 2009
Diagnostic assaysErwin Schleicher
Analytical and Bioanalytical Chemistry|December 3, 2005
The clinical chemistry laboratory: current status, problems and diagnostic prospectsErwin Schleicher
Analytical and Bioanalytical Chemistry|December 24, 2008
Inflammation markers in point-of-care testing (POCT)Albrecht Pfäfflin, Erwin Schleicher
Clinical Chemistry and Laboratory Medicine|August 1, 2009
Impeded centrifugation in plasmocytoma serumAlbrecht Pfäfflin, Erwin Schleicher
Annals of Clinical Biochemistry|January 20, 2009
Interference of paracetamol (acetaminophen) with a commercially available high-performance liquid chromatography analysis of serotonin leading to falsely low serotonin levelsAlbrecht Pfäfflin, Karsten Müssig, Erwin Schleicher
Analytical and Bioanalytical Chemistry|November 20, 2010
Production and analytical characterization of neopterin immunoreagents for biosensor developmentsIvo Cernoch, Erwin Schleicher, Milan Franek
Annals of the New York Academy of Sciences|May 2, 2008
The 9th International Symposium on the Maillard Reaction. PrefaceErwin Schleicher, Veronika Somoza, Peter Schieberle
Clinical Chemistry|October 24, 2007
3-O-methyldopamine (3-O-methoxytyramine) interferes with the internal standard 3,4-dihydroxybenzylamine in a plasma catecholamine HPLC methodAlbrecht Pfäfflin, Erwin Schleicher, Karsten Müssig
Clinical Kidney Journal|February 10, 2021
Urinary fetuin-A peptides as a new marker for impaired kidney function in patients with type 2 diabetesPedro Magalhães, Petra Zürbig, Harald Mischak, et al.
Biotechnology Advances|February 26, 2019
Harmonization of immunoassays for biomarkers in diabetes mellitusSebastian Hörber, Peter Achenbach, Erwin Schleicher, et al.
Pageof 10